Creative Planning
VIR icon

Creative Planning’s Vir Biotechnology VIR Stock Holding History

Creative Planning’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$901K Buy
100,511
+20,815
+26% +$166K ﹤0.01% 2546
2025
Q4 		$481K Buy
79,696
+27,020
+51% +$161K ﹤0.01% 2879
2025
Q3 		$301K Buy
52,676
+14,917
+40% +$76.3K ﹤0.01% 3143
2025
Q2 		$190K Buy
37,759
+25,760
+215% +$138K ﹤0.01% 3241
2025
Q1 		$77.8K Sell
11,999
-2,189
-15% -$19.5K ﹤0.01% 3288
2024
Q4 		$104K Buy
+14,188
New +$112K ﹤0.01% 3151
2024
Q3 		– Sell
-27,198
Closed -$242K – 3322
2024
Q2 		$242K Buy
27,198
+5,385
+25% +$51.6K ﹤0.01% 2525
2024
Q1 		$221K Buy
21,813
+4,657
+27% +$47.4K ﹤0.01% 2502
2023
Q4 		$173K Buy
+17,156
New +$157K ﹤0.01% 2476

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Creative Planning's VIR Position: Q1 2026 in Review

Creative Planning increased its Vir Biotechnology (VIR) stake by 26% in Q1 2026, buying an estimated $166K and bringing the position to 100,511 shares worth $901K. The position accounts for ﹤0.01% of the portfolio, ranked #2546.

Creative Planning first reported a position in VIR in Q4 2023 and has held it in 9 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Creative Planning held 100,511 shares of Vir Biotechnology worth $901K as of Q1 2026.
  • Creative Planning bought 20,815 Vir Biotechnology shares in Q1 2026, an estimated $166K.
  • Vir Biotechnology made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2546 holding.
  • Creative Planning first reported a position in Vir Biotechnology in Q4 2023 and has held it in 9 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.